Terry Lappin’s “words” (e-mail to ARM in February 2024): “There has been a long debate and I think it is fair to say that generally the Pharma companies set out in rather cavalier fashion to deny, or at least downplay, the existence of EPO receptors in tumor tissue, whereas ...